BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gao YF, Yu L, Wei W, Li JB, Luo QL, Shen JL. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA. World J Gastroenterol 2008; 14(29): 4684-4689 [PMID: 18698684 DOI: 10.3748/wjg.14.4684]
URL: https://www.wjgnet.com/1007-9327/full/v14/i29/4684.htm
Number Citing Articles
1
Pranjal Yadava. RNAi Technology2011; : 113 doi: 10.1201/b10882-7
2
Pranjal Yadava, Sunil Kumar Mukherjee. Regulatory RNAs2012; : 505 doi: 10.1007/978-3-642-22517-8_20
3
Nattanan Panjaworayan, Chris M. Brown. Effects of HBV Genetic Variability on RNAi StrategiesHepatitis Research and Treatment 2011; 2011: 1 doi: 10.1155/2011/367908
4
Wei Hu, Ting Li, Mu Li, Lei Wu, Xingyu Meng, Yuhua Tian. Effects of microRNA-mediated IGF-1 gene silencing on telomerase activity and cell proliferation in deer antler cellsCanadian Journal of Animal Science 2014; 94(3): 417 doi: 10.4141/cjas2013-050
5
Cheng-Guo Duan, Chun-Han Wang, Hui-Shan Guo. Application of RNA silencing to plant disease resistanceSilence 2012; 3(1) doi: 10.1186/1758-907X-3-5
6
Douglas Mogul, Michael Torbenson, Kathleen B. Schwarz. Epigenetic Regulation of Hepatitis B Virus InfectionCurrent Hepatitis Reports 2011; 10(4): 277 doi: 10.1007/s11901-011-0113-3
7
Jiang Li, Jianqin Lu, Yifei Zhang, Mohammed Ghazwani, Peng Zhang, Xiang Gao, Song Li. Advanced Delivery and Therapeutic Applications of RNAi2013; : 327 doi: 10.1002/9781118610749.ch15
8
Gang Li, Xiaojia Xiong. MicroRNAs and hepatitis virusesFrontiers of Medicine in China 2009; 3(3): 265 doi: 10.1007/s11684-009-0055-0
9
Maged Gomaa Hemida, Xin Ye, Simone Thair, Decheng Yang. Exploiting the Therapeutic Potential of MicroRNAs in Viral DiseasesMolecular Diagnosis & Therapy 2010; 14(5): 271 doi: 10.1007/BF03256383
10
Anna Kotowska‐Zimmer, Marianna Pewinska, Marta Olejniczak. Artificial miRNAs as therapeutic tools: Challenges and opportunitiesWIREs RNA 2021; 12(4) doi: 10.1002/wrna.1640
11
Pranjal Yadava, Sunil Kumar Mukherjee. Regulatory RNAs2012; : 505 doi: 10.1007/978-3-642-22517-8_20
12
Shazia Tabassum Hakim, Cayatineto HW. Prospective approaches to target bovine viral diarrhea virus and hepatitis C virus using miRNA-based inhibitorsJournal of Human Virology & Retrovirology 2024; 11(1): 36 doi: 10.15406/jhvrv.2024.11.00278
13
Ailbhe M. McDermott, Helen M. Heneghan, Nicola Miller, Michael J. Kerin. The Therapeutic Potential of MicroRNAs: Disease Modulators and Drug TargetsPharmaceutical Research 2011; 28(12): 3016 doi: 10.1007/s11095-011-0550-2
14
Raquel Calloni, Diego Bonatto. Scaffolds for Artificial miRNA Expression in Animal CellsHuman Gene Therapy Methods 2015; 26(5): 162 doi: 10.1089/hgtb.2015.043
15
Junzheng Du, Shandian Gao, Jihuai Luo, Guofeng Zhang, Guozheng Cong, Junjun Shao, Tong Lin, Xuepeng Cai, Huiyun Chang. Effective inhibition of foot-and-mouth disease virus (FMDV) replication in vitro by vector-delivered microRNAs targeting the 3D geneVirology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-292
16
Tingfan Zhu, Jinhan Qian, Zijun Shen, Hongxia Shao, Kun Qian, Wenjie Jin, Aijian Qin. Vector-delivered artificial miRNA effectively inhibits Porcine epidemic diarrhea virus replicationVirology Journal 2023; 20(1) doi: 10.1186/s12985-023-02129-5
17
Yingying Mao, Xuejun Wang, Wei Hu, Andrew Li, Ying Li, Hai Huang, Renhe Yan, Yanling Zhang, Jinlong Li, Hongwei Li, Shengqi Wang. Long-term and efficient inhibition of hepatitis B virus replication by AAV8-delivered artificial microRNAsAntiviral Research 2022; 204: 105366 doi: 10.1016/j.antiviral.2022.105366
18
Lili Guo, Xiang Yang, Tao Duan. Altered microRNA expression profile in maternal and fetal liver of HBV transgenic mouse modelThe Journal of Maternal-Fetal & Neonatal Medicine 2012; 25(10): 2071 doi: 10.3109/14767058.2012.678431
19
Chun-Mei Wang, Yan Wang, Chun-Guang Fan, Fei-Fei Xu, Wen-Sheng Sun, Yu-Gang Liu, Ji-Hui Jia. miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinomaBiochemical and Biophysical Research Communications 2011; 411(3): 586 doi: 10.1016/j.bbrc.2011.06.191
20
Xiya Lu, Fei Wang. MicroRNA2022; : 549 doi: 10.1016/B978-0-323-89774-7.00009-1